Medical Doctor Program year 2024 Reported 2020–2024 Source: CMS Open Payments, 2026 publication

Leon Scott

Sports Medicine Nashville, TN Medical Doctor

NPI 1215105895 CMS profile 54490

3601 The Vanderbilt Clinic, Nashville, TN 37232

Open in the dashboard

General payments

$631

2 records reported · program years 2020–2024

Research payments

$0

Paid to them · None reported · program years 2020–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Leon Scott of Nashville, TN is reported in the CMS Open Payments database as having received $631 across 2 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $114 1
2020 General $517 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Leon Scott
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Leon Scott were reported at $0. Among 72 Sports Medicine profiles paid that year, the median was $60 and the middle half received between $25 and $144.

Show as a table
Year Leon Scott Sports Medicine median Middle half National median
2019 $0 $60 $32–$131 $163
2020 $517 $37 $21–$143 $114
2021 $0 $75 $28–$196 $132
2022 $0 $66 $24–$131 $149
2023 $0 $95 $35–$136 $160
2024 $114 $93 $29–$172 $164
2025 $0 $60 $25–$144 $169

Breakdown

Who paid General payments · program years 2020–2024
  1. Alpha Orthopedic Systems $517 1 payment
  2. Trice Medical, Inc. $114 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2024
  1. Education $517 1 payment
  2. Food and Beverage $114 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

186

Median for Pediatric Medicine: 38

Drug cost

$1,301

Median for Pediatric Medicine: $2,769

Branded share of claims

9.1%

Median for Pediatric Medicine: 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 46 $572
Meloxicam Generic 76 $242
Celecoxib Generic 15 $225
Methylprednisolone Generic 32 $197
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 17 $64

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,361 Part D prescribers listed as Pediatric Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$58,784

Of which drugs: $11,906

Medicare patients

323

Average age 74

Services billed

5,943

199 women, 124 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Ischemic heart disease 27%
Depression 23%
Chronic kidney disease 21%
Diabetes 19%
Atrial fibrillation 18%
Cancer 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg J7325 Office 15 1,392 $9,850
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 97 694 $478
Injection, methylprednisolone acetate, 1 mg J1010 Office 53 2,920 $272
Injection, methylprednisolone acetate, 40 mg J1030 Office 19 27 $106

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

2 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record